All Disease Treatment & Prevention articles – Page 2
-
NewsSteroids reduce inflammation in chronic mycobacterial lung infections without limiting antimicrobial defence
Researchers have shown that dexamethasone, a commonly prescribed anti-inflammatory steroid, can reduce harmful inflammation triggered by Mycobacterium avium without weakening the ability of human immune cells to control the infection.
-
NewsAncient bacterial signals from cell powerhouses may fuel excessive inflammation
Researchers have discovered that proteins released from mitochondria can activate the immune system in a similar way to invading bacteria, suggesting that remnants of mitochondria’s evolutionary past may contribute to inflammation.
-
NewsLong-acting therapies continue to gain momentum in HIV, says GlobalData
The next phase of competition in the HIV market will be defined not only by achieving viral suppression, but improving treatment adherence, reducing medication burden and delivering more convenient treatment options, says a new analysis.
-
NewsTriple-dose regimen may permanently clear HIV in infected newborns
New research suggests a one-time regimen of therapies given to newborns within three days of birth could permanently clear HIV infection.
-
NewsNew viral marker strategies improve prediction of functional cure in chronic hepatitis B
Researchers identify how combining classical and emerging viral biomarkers can better predict functional cure and guide individualized hepatitis B treatment.
-
NewsWhen fever isn’t the answer: Infected tadpoles cool themselves to fight viruses
Researchers have experimentally demonstrated that an ectothermic vertebrate infected with a virus actively seeks cooler, rather than warmer, environments to regulate its body temperature.
-
NewsStudy finds HIV-1 proviruses may drive chronic systemic inflammation
People living with HIV are at higher risk of developing inflammatory diseases of many tissues, even when receiving antiviral treatments. A new study suggests that persistent hidden HIV contributes to this inflammation.
-
NewsObesity drug significantly reduces the risk of infections and serious cardiovascular events
Tirzepatide, marketed under the brand name Mounjaro, could reduce the risk of heart attacks and hospitalizations due to infections in people with type 2 diabetes by by about one-third when compared with a conventional diabetes medication.
-
NewsResearchers uncover unexpected twist in fight against antibiotic resistance
A group of Cornell College students and their professor have discovered surprising results in their research on antimicrobial peptides, which are being studied as a method of combating antibiotic resistance.
-
NewsMeningococcal B vaccine linked to lower gonorrhoea risk
The meningococcal B vaccine could provide protection against more than one disease, with new research linking it to a significant reduction in the risk of gonorrhoea in young people in Australia.
-
NewsResearchers develop new drug to attack an enduring killer
Researchers have developed a new antimalarial drug designed to thwart even the most drug-resistant forms of the infection.
-
NewsLong non-coding RNAs offer new hope for earlier detection and improved treatment of liver cancer linked to hepatitis B
Long non-coding RNAs may play a pivotal role in shaping the future of diagnosis, prognosis, and treatment in HBV-associated liver disease.
-
NewsAdults living with HIV are at high risk for diabetes. Here’s why.
A new study helps explain why people with HIV remain at elevated risk for type 2 diabetes despite effective suppression of the virus with modern medications.
-
NewsDoes eczema increase the risk of developing shingles?
New research indicates that people with eczema face an elevated risk of developing shingles.
-
NewsPromising single-dose malaria treatment advances toward pan-African clinical trial
A promising single-dose malaria treatment that could help address growing drug resistance and simplify treatment for patients.
-
NewsIntratumoral Fusobacterium as a prognostic and predictive biomarker in resectable colorectal cancer
Research supports the use of Fusobacterium as a prognostic and predictive biomarker in patients with resectable stage I–III CRC. Its presence was associated with more aggressive disease, a weaker immune response, and limited benefit from adjuvant chemotherapy.
-
NewsNew therapy eliminates gum disease bacterium while preserving beneficial oral microbes
Researchers have created an innovative treatment for periodontitis that targets and eliminates harmful bacteria while preserving beneficial oral microbes essential for health.
-
NewsEffect of a novel enteral nutrition mixture with probiotics versus standard enteral nutrition on gastrointestinal complications in critically ill surgical patients
A randomised controlled trial conducted in critically ill patients recovering from abdominal surgery found that a novel probiotic-enriched tube feeding formula reduced serious gut complications dramatically compared to standard enteral nutrition.
-
NewsResearch funding to improve treatment for invasive fungal infections
The Federal Joint Committee is funding a new Germany-wide research project aimed at improving care for patients with invasive fungal infections.
-
NewsThinking beyond antibiotics in the treatment of urinary tract infections
A promising new study combines phage therapy (PT) with fecal microbiota transplantation (FMT) to treat recurrent urinary tract infections.